- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
How Evox is engineering a new class of therapeutics
Chief executive Antonin de Fougerolles talks about Evox’s journey to commercialising a new modality that could prove truly transformational.
Apr 29, 2021CytoSeek chases cell therapy’s holy grail
The University of Bristol spinout is working on adapting cell therapies to solid tumours.
Apr 29, 2021Assurant Ventures achieves $100m of investments
Insurance provider Assurant's corporate venturing unit has had three portfolio companies enter reverse merger deals since the start of March.
Apr 29, 2021Alchemy turns interest into $80m
Coinbase and Genies both participated in a series B round that pushed the blockchain infrasructure provider's valuation past $500m.
Apr 29, 2021Pfizer finds cash for Amplyx acquisition
Fungal infection treatment developer Amplyx Pharmaceuticals had disclosed $142m in funding from investors including Pfizer and Lundbeckfonden Ventures.
Apr 29, 2021Daily Deal Round Up: April 28, 2021
Applied Ventures helped assay provider Ultivue close a $50m round while clean energy producer Sunseap has followed a $72m series D4 round with more corporate funding.
Apr 28, 2021Zomato sums up $1.1bn IPO plans
The food ordering app developer's largest shareholder, Info Edge, is set to sell $100m of shares in the proposed dual offering.
Apr 28, 2021Eutelsat puts $550m into OneWeb
The satellite operator is set to acquire approximately 24% of satellite internet constellation developer OneWeb, which already has several corporate backers.
Apr 28, 2021Tuya teams with Hillhouse for $400m fund
The internet-of-things provider will back companies in similar sectors through the vehicle, launched in partnership with Hillhouse Capital.
Apr 28, 2021Greenlight waves in Wells Fargo to raise $260m
Wells Fargo Strategic Capital was among the investors in a series D round valuing the child-focused banking platform developer at $2.3bn.
Apr 28, 2021Current flows with $220m series D round
The CMFG Ventures-backed challenger bank’s latest round valued it at $2.2bn and pushed its total funding past $400m.
Apr 28, 2021Exscientia checks off $225m series D
The artificial intelligence drug developer has closed a $225m round led by SoftBank Vision Fund 2, which has offered a further $300m in funding.
Apr 28, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
